Ann: Imagion to develop nanocrystals for treating breast cancer, page-29

This was from May 18, 2017 in a SEC GCT filing for future plans for them and the collaboration with Imagion Scientifics...

Go to Market Strategy

We are actively seeking a strategic partner for initiating our preclinical studies. We are currently in negotiations to enter into an agreement with Imagion Biosystems, a San Diego company who is a leader in the use of nano crystal scintillators and iron oxide particles for a new and advanced imaging technique. If successful, we will create the first nano crystal scintillator carrying the ability to image a tumor and simultaneously treat the tumor with the therapeutic agent. If completed, this partnership with Imagion Biosystems will produce a large part of preclinical data that we will integrate with other strategic partners we are developing for the preclinical work. We are currently seeking funding for these activities.